Lisata Therapeutics Inc (LSTA): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Lisata Therapeutics Inc (LSTA) following the 2026 Q1 hedge fund 13F filings?

As of today, LSTA has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), LSTA gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Lisata Therapeutics Inc (LSTA)

33 + Investors. Track Smart Money conviction in LSTA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — LSTA

Based on 33 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added LSTA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

33 hedge funds hold LSTA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +50% more funds vs a year ago

fund count last 6Q

+11 new funds entered over the past year (+50% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 69% buying

18 buying8 selling

Last quarter: 18 funds were net buyers (13 opened a brand new position + 5 added to an existing one). Only 8 were sellers (2 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter

Funds opening a new LSTA position: 3 → 5 → 7 → 13. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 30% long-term, 45% new

■ 30% conviction (2yr+) ■ 24% medium ■ 45% new

Of the 33 current holders: 10 (30%) held >2 years, 8 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💰

Value +264% but shares only +45% — price-driven

Value

+264%

+45%

Last quarter: the total dollar value of institutional holdings rose +264%, but actual share count only changed +45%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

5 → 3 → 5 → 7 → 13 new funds/Q

New funds entering each quarter: 3 → 5 → 7 → 13. A growing number of institutions are discovering LSTA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 55% of holders entered in last year

■ 36% veterans ■ 9% 1-2yr ■ 55% new

Of 33 current holders: 18 (55%) entered in the past year, only 12 (36%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds

10 of 33 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.9

out of 10

Moderate Exit Risk

Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	33	26	26.92%
13F Shares	1M	727K	45.3%
Total Value	$5M	$1M	264.43%
New Positions	13	7	+6
Increased Positions	5	6	-1
Closed Positions	6	3	+3
Reduced Positions	2	6	-4
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

26.92%

13F Shares

727K

45.3%

Total Value

$5M

$1M

264.43%

New Positions

Increased Positions

-1

Closed Positions

Reduced Positions

-4

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

33 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LSTA. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 LSTA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Rangeley Capital, LLC	0.37%	75,000	$376K
2	Deltec Asset Management LLC	0.08%	90,000	$451K
3	PenderFund Capital Management Ltd.	0.04%	47,500	$238K
4	Css LLC/Il	0.01%	61,898	$310K
5	SOL Capital Management CO	0.01%	12,175	$29K
6	JBF Capital, Inc.	0.01%	13,234	$66K
7	Gts Securities LLC	0.01%	31,396	$157K
8	Connective Capital Management, LLC	0.00%	1,016	$5K
9	Founders Capital Management	0.00%	1,667	$8K
10	International Assets Investment Management, LLC	0.00%	5,000	$25K
11	Renaissance Technologies LLC	0.00%	131,715	$660K
12	Tower Research Capital LLC (TRC)	0.00%	785	$4K
13	Cerity Partners LLC	0.00%	12,183	$61K
14	HighTower Advisors, LLC	0.00%	10,042	$50K
15	Vanguard Fiduciary Trust Co	0.00%	34,917	$175K
16	Vanguard Capital Management LLC	0.00%	271,815	$1.4M
17	Caitong International Asset Management Co., Ltd	0.00%	22	—
18	Citadel Advisors LLC	0.00%	22,666	$114K
19	Susquehanna International Group, LLP	0.00%	11,604	$58K
20	Royal Bank of Canada	0.00%	5,873	$29K
21	BlackRock, Inc.	0.00%	54,857	$275K
22	Bank of America Corp /de/	0.00%	10,353	$52K
23	Cheviot Value Management, LLC	0.00%	3	—
24	Osaic Holdings, INC.	0.00%	200	$1K
25	UBS Group AG	0.00%	1,909	$10K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Lisata Therapeutics Inc (LSTA)

What does the Smart Money Trend signal show for LSTA?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added LSTA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for LSTA?

More buyers than sellers — 69% buying: Last quarter: 18 funds were net buyers (13 opened a brand new position + 5 added to an existing one). Only 8 were sellers (2 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for LSTA holders?

Smaller funds dominant — 16% AUM from top-100: 10 of 33 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held LSTA?

Mixed — 30% long-term, 45% new: Of the 33 current holders: 10 (30%) held >2 years, 8 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Lisata Therapeutics Inc (LSTA) following the 2026 Q1 hedge fund 13F filings?

As of today, LSTA has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), LSTA has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Lisata Therapeutics Inc (LSTA)

Smart Money Signals — LSTA

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +50% more funds vs a year ago

More buyers than sellers — 69% buying

More new buyers each quarter (+6 vs last Q)

Mixed — 30% long-term, 45% new

Value +264% but shares only +45% — price-driven

Growing discovery — still being found

Early stage — 55% of holders entered in last year

Smaller funds dominant — 16% AUM from top-100

Institutional Sentiment Summary — LSTA

Hedge Fund Ownership: LSTA

Market Analysis: LSTA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: LSTA

Is It Too Late to Buy Lisata Therapeutics Inc (LSTA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: LSTA

Statistics: LSTA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Lisata Therapeutics Inc (LSTA)

Welcome to 13Foresight!